Intraventricular thrombolysis for massive intraventricular hemorrhage due to periventricular arteriovenous malformations. No absolute contraindications as rescue therapy prior to surgical repair or embolization?

Clinical Neurology and Neurosurgery

Volumn 111, Issue 6, 2009, Pages 544-550

  Jorens, Philippe G ^a   Menovsky, Tomas M ^a   Voormolen, Maurits H ^a   Van Den Brande, Els ^b   Parizel, Paul M ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b Stuivenberg General Hospital   (Belgium)

Author keywords

Arteriovenous; Brain; Cerebral; Hemorrhage; Intraventricular; Malformation; rt PA; Thrombolysis; tPA

Indexed keywords

ALTEPLASE; BARBITURIC ACID DERIVATIVE;

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; BLOOD CLOT LYSIS; BRAIN ANGIOGRAPHY; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN HEMORRHAGE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CRANIOTOMY; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; GLASGOW OUTCOME SCALE; HUMAN; IMAGE ANALYSIS; INTRACRANIAL PRESSURE; LOW DRUG DOSE; OUTCOME ASSESSMENT; SURGICAL TECHNIQUE; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

ADULT; CEREBRAL HEMORRHAGE; CEREBRAL VENTRICLES; COMBINED MODALITY THERAPY; EMBOLIZATION, THERAPEUTIC; FEMALE; FIBRINOLYTIC AGENTS; GLASGOW OUTCOME SCALE; HUMANS; INJECTIONS, INTRAVENTRICULAR; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; PREGNANCY; RECOMBINANT PROTEINS; SALVAGE THERAPY; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67349093500     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2009.02.006     Document Type: Article

References (27)

1. Andrews C.O., and Engelhard H.H. Fibrinolytic therapy in intraventricular hemorrhage. Ann Pharmacother 35 11 (2001) 1435-1448
2. Vereecken K.K., Van Havenbergh T., De Beuckelaar W., Parizel P.M., and Jorens P.G. Treatment of intraventricular hemorrhage with intraventricular administration of recombinant tissue plasminogen activator A clinical study of 18 cases. Clin Neurol Neurosurg 108 5 (2006) 451-455
3. Graeb D.A., Robertson W.D., Lapointe J.S., Nugent R.A., and Harrison P.B. Computed tomographic diagnosis of intraventricular hemorrhage. Etiology and prognosis. Radiology 143 1 (1982) 91-96
4. Tuhrim S., Horowitz D.R., Sacher M., and Godbold J.H. Volume of ventricular blood is an important determinant of outcome in supratentorial intracerebral hemorrhage. Crit Care Med 27 3 (1999) 617-621
5. Broderick J.P., Brott T.G., Duldner J.E., Tomsick T., and Huster G. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke 24 7 (1993) 987-993
6. Young W.B., Lee K.P., Pessin M.S., Kwan E.S., Rand W.M., and Caplan L.R. Prognostic significance of ventricular blood in supratentorial hemorrhage: a volumetric study. Neurology 40 4 (1990) 616-619
7. Keller T.M., Corkill G., and Ellis W.G. Persistent isodense intraventricular hematoma caused by intraventricular saccular aneurysm. Surg Neurol 13 3 (1980) 177-180
8. Nyquist P., LeDroux S., and Geocadin R. Thrombolytics in intraventricular hemorrhage. Curr Neurol Neurosci Reports 7 6 (2007) 522-528
9. Sumner C.J., Golden J.A., and Hemphill III J.C. Should thrombolysis be contraindicated in patients with cerebral arteriovenous malformations?. Crit Care Med 30 10 (2002) 2359-2362
10. Spetzler R.F., and Martin N.A. A proposed grading system for arteriovenous malformations. J Neurosurg 65 4 (1986) 476-483
11. Rohde V., Schaller C., and Hassler W.E. Intraventricular recombinant tissue plasminogen activator for lysis of intraventricular haemorrhage. J Neurol Neurosurg Psychiatry 58 4 (1995) 447-451
12. Goh K.Y., and Poon W.S. Recombinant tissue plasminogen activator for the treatment of spontaneous adult intraventricular hemorrhage. Surg Neurol 50 6 (1998) 526-531 discussion 531-2
13. Mayfrank L., Rohde V., and Gilsbach J.M. Fibrinolytic treatment of intraventricular haemorrhage preceding surgical repair of ruptured aneurysms and arteriovenous malformations. Br J Neurosurg 13 2 (1999) 128-131
14. Kumar K., Demeria D.D., and Verma A. Recombinant tissue plasminogen activator in the treatment of intraventricular hemorrhage secondary to periventricular arteriovenous malformation before surgery: case report. Neurosurgery 52 4 (2003) 964-968 discussion 968-9
15. Le Roux P.D., Haglund M.M., Newell D.W., Grady M.S., and Winn H.R. Intraventricular hemorrhage in blunt head trauma: an analysis of 43 cases. Neurosurgery 31 4 (1992) 678-684 discussion 684-5
16. Jennett B., and Bond M. Assessment of outcome after severe brain damage. Lancet 1 7905 (1975) 480-484
17. Findlay J.M., Grace M.G., and Weir B.K. Treatment of intraventricular hemorrhage with tissue plasminogen activator. Neurosurgery 32 6 (1993) 941-947 discussion 947
18. The Arteriovenous Malformation Study Group. Arteriovenous malformations of the brain in adults. New Engl J Med 1999;340(23):1812-18.
19. Friedlander R.M. Clinical practice. Arteriovenous malformations of the brain. New Engl J Med 356 26 (2007) 2704-2712
20. Naff N.J., Carhuapoma J.R., Williams M.A., Bhardwaj A., Ulatowski J.A., Bederson J., et al. Treatment of intraventricular hemorrhage with urokinase: effects on 30-day survival. Stroke 31 4 (2000) 841-847
21. Fountas K.N., Kapsalaki E.Z., Parish D.C., Smith B., Smisson H.F., Johnston K.W., et al. Intraventricular administration of rt-PA in patients with intraventricular hemorrhage. South Med J 98 8 (2005) 767-773
22. Varelas P.N., Rickert K.L., Cusick J., Hacein-Bey L., Sinson G., Torbey M., et al. Intraventricular hemorrhage after aneurysmal subarachnoid hemorrhage: pilot study of treatment with intraventricular tissue plasminogen activator. Neurosurgery 56 2 (2005) 205-213 discussion 205-213
23. Sloan M.A., Price T.R., Petito C.K., Randall A.M., Solomon R.E., Terrin M.L., et al. Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience. Neurology 45 4 (1995) 649-658
24. Proner J., Rosenblum B.R., and Rothman A. Ruptured arteriovenous malformation complicating thrombolytic therapy with tissue plasminogen activator. Arch Neurol 47 1 (1990) 105-106
25. Gore J.M., Sloan M., Price T.R., Randall A.M., Bovill E., Collen D., et al. Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial. Circulation 83 2 (1991) 448-459
26. Jafar J.J., Tan W.S., and Crowell R.M. Tissue plasminogen activator thrombolysis of a middle cerebral artery embolus in a patient with an arteriovenous malformation: case report. J Neurosurg 74 5 (1991) 808-812
27. Fuse T., Niwa Y., and Harada S. Local intraarterial fibrinolytic therapy for embolic stroke associated with vascular anomalies-two case reports. Neurol Med Chir (Tokyo) 40 12 (2000) 641-644